Alnylam Pharmaceuticals
ALNY
#870
Rank
$29.17 B
Marketcap
$218.00
Share price
-0.55%
Change (1 day)
-49.89%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company